Elisa Diagnostic Test Market Scope And Analysis

Report Code : TIPRE00030120
Category : Life Sciences

Status : Published
No. of Pages : 199

Buy Now

ELISA Diagnostics Tests Market Scope, Analysis, and Trends by 2031

Buy Now

ELISA Diagnostics Tests Market Report Scope

Report Attribute	Details
Market size in 2022	US$ 1,285.49 Million
Market Size by 2030	US$ 2,271.23 Million
Global CAGR (2022 - 2030)	7.37%
Historical Data	2020-2021
Forecast period	2022-2030
Segments Covered	By Adoption Human and Veterinary By Test Type Sandwich ELISA Indirect ELISA Competitive ELISA Multiple & Portable ELISA By Application Autoimmune Diseases Infectious Diseases Cancer Diagnosis Protein Quantification By End User Hospitals & Diagnostic Centers Pharmaceutical & Biotechnology Companies Veterinary Hospitals & Diagnostic Laboratories
Regions and Countries Covered	North America US Canada Mexico Europe UK Germany France Russia Italy Rest of Europe Asia-Pacific China India Japan Australia Rest of Asia-Pacific South and Central America Brazil Argentina Rest of South and Central America Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	Bio Rad Laboratories Inc Idexx Laboratories Inc F Hoffmann La Roche Ltd Thermo Fisher Scientific Inc Abbott Laboratories Danaher Corp Innovative Diagnostics Pictor Ltd DiaSorin SpA Elabscience Biotechnology Inc

ELISA Diagnostics Tests Market News and Recent Developments

The ELISA diagnostics tests market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the ELISA diagnostics tests market are listed below:

Charles River Laboratories International, Inc. launched its first Enzyme-Linked Immunosorbent Assay (ELISA) Kit for the detection and quantitation of residual host cell proteins (HCP) in CHO-based biotherapeutics. (Source: Charles River, Company Website, February 2023)
Neogen Corporation launched its innovative Veratox VIP assay for the detection of walnut, the third assay in Neogen's Veratox VIP line of enhanced quantitative ELISA products. (Source: Neogen Corporation, Press Release, November 2023)
Quest Diagnostics has been granted breakthrough device designation from the U.S. Food and Drug Administration (FDA) for AAVrh74 ELISA assay (CDx). (Source: Quest Diagnostics, Newsletter, September 2023)

ELISA Diagnostics Tests Market Report Coverage and Deliverables

The “ELISA Diagnostics Tests Market Size and Forecast (2020–2030)” report provides a detailed analysis of the market covering below areas:

ELISA diagnostics tests market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
ELISA diagnostics tests market trends as well as market dynamics such as drivers, restraints, and key opportunities
Detailed PEST/Porter’s Five Forces and SWOT analysis
ELISA diagnostics tests market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the ELISA diagnostics tests market
Detailed company profiles